Tiffany Stevens
@ECTAdvisor
Physician at Expert Clinical Trial Advisor
You might like
It was ☀️ today but not very warm so they took much longer to dry - hence I didn’t get them all done. Hopefully can finish them tomorrow 🤞🏽 Anyway, 💙🩵🩷❤️💜♥️
Sunrise at Stonehenge today (19th December) was at 8.06am, sunset is at 4.00pm ☀️
One of the year’s highlights and a real treat to welcome back @DrHBurstein to this webinar for patients living with MBC. Save the date!
New #EMBRACE webinar for patients and loved ones! Join Dr. Hal Burstein (@DrHBurstein) on Jan 16th to hear the latest updates on treatment and research breakthroughs for #MetastaticBreastCancer from the 2025 San Antonio #BreastCancer Symposium #SABCS25. A Q&A will follow the…
My work came in the Top articles of the year in @ASCO Global oncology journal @JCOGO_ASCO for 3 years out of the last four. #globaloncology
⚡️ @NEJM - IMvigor011 takes perioperative Bladder Cancer care a step further. ctDNA-guided adjuvant atezolizumab in ctDNA+ pts after cystectomy improved DFS (9.9 vs 4.8 mo) and OS (32.8 vs 21.1 mo) vs placebo, while ctDNA– pts safely avoided adjuvant IO. #bladdercancer…
New from Dr. Bradley A. Erickson in @EurUrolFocus: How Artificial Urinary Sphincter Impacts Toileting Habits 1 Year After Implantation. buff.ly/YIaYKXP
✈️ Chicago to Seattle — can’t wait to land & catch up with great friends and colleagues. #WindowSeat #FlightViews 🌆→ 🌙 @PGrivasMDPhD @PavlosMsaouel @DimaDanai @LeiDeng3 @mecmededucation @PearlJam
⭐️ What’s the BEST first treatment for our patients with diffuse large B-cell lymphoma after #ASH25 ? Full video 👉 lnkd.in/ePsTVRYM I sat down with Dr. @JoshuaBrodyMD to unpack this important question on @OncLive — diving into real-world decision points, and the…
Thanks @oncodaily and @CParkMD for such a fun and meaningful discussion. We discuss ✅need for educational platforms tailored to our reducing attention spans ✅challenges and wins around trials- that make true impact on our patients lives ✅power of network and taking care of…
youtube.com
YouTube
Empowering Oncologists: How going out of comfort zone is foundational...
The challenge of getting past Whatiffery applies to the whole clinical journey from referral to ED through to discharge ?
🐝 Still buzzing from #ESMO25 💫 Science. Friendship. Purpose. #ESMO25 had it all 🔬✨💪 Appearances by 🎥 @curijoey @stolaney1 @DrChoueiri @StephenVLiu @NarjustFlorezMD @CathyEngMD @VanMorrisMD @herbloong @VivekSubbiah @PGrivasMDPhD @shilpaonc @TiansterZhang…
Unforgettable evening at the SMRU-ASRM event in San Antonio, honoring Dr. Peter Schlegel with the Distinguished Service Award and my mentor, Dr. Robert Oates with the prestigious Lifetime Achievement Award. Their groundbreaking contributions to male reproductive medicine will…
New study in @urogoldjournal from Dr. Bradley A. Erickson shows that use of suprapubic tube is a viable long-term solution for select patients with neurogenic bladder. Secondary urologic procedures may be required, and for long-term use, a urologist should place the tube.…
👏 Such an inspiring evening celebrating Dr. Stephen Freedland, Dr. Neal Shore, and the EMBARK study investigators ! Click here NEJM just released 👉 nejm.org/doi/full/10.10… Over dinner, we reflected on more than a decade of dedication by the EMBARK study team that led to this…
🙏 Thank you Dr. Brian Rini, Dr. Katy Beckermann , Dr. Petros Grivas, Dr. David Aggen, Dr. Neal Shore, and Dr. Neeraj Agarwal for joining me on @OncLive @UrologyTimes on Location. Click here 👉 onclive.com/view/rounding-… ❤️ talking about all of the practice changing data GU…
💡Just released Practice changing study in NEJM👉 Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer. PFS DV vs chemo (median, 13.1 vs. 6.5 months; Overall survival DV vs Chemo (31.5 vs. 16.9 months;) objective response was DV 76.1% (95% CI, 70.3…
⭐️Dr. Alicia Morgans, Dr. Daniel George and IDEOlogy Health hit all the right notes at the #WorldGU25 conference @CMATheater in Nashville! ✨ Cutting-edge panel discussions on kidney, bladder, and prostate cancers ✨ Inspirational talks from cancer patients reminding us why…
⭐️ Great new #ASCO25 stats by @OncoAlert and @medicalwatchBC 👉 my.medical.watch/oncoalert/hash… @GlopesMd @yekeduz_emre @realbowtiedoc @OncBrothers @bavilima @nataliagandur @FernandoOnco @ElisaAgostinett @PGrivasMDPhD @FadiHaddad_MD @Lucarecco @JankovicK @GaiaGriguolo @crisbergerot…
Diagnostic and therapeutic advances are reshaping how we treat GU cancers — and Dr. @DrRanaMcKay is at the forefront of the conversation at #ASCO25 A dynamic education session spotlighting evolving paradigms and precision approaches in #GUonc @ASCO
Facts about Pope Leo XIV >IQ: 145 >Speaks 7 languages >Former professor >Degrees in mathematics & theology >Missionary in Peru for +10 years >First American Pope >Known for humility and intellectual capabilities This isn’t just a Pope This is one of the smartest men alive
United States Trends
- 1. The Jupiter 342 B posts
- 2. FINALLY DID IT 570 B posts
- 3. Brigitte Bardot 148 B posts
- 4. Good Sunday 70 B posts
- 5. namjoon 72,6 B posts
- 6. Tonges 1.267 posts
- 7. Sunday of 2025 15,1 B posts
- 8. #sundayvibes 4.744 posts
- 9. #AskFFT N/A
- 10. Cyclops 12,5 B posts
- 11. X-Men 31,2 B posts
- 12. Kittle 2.907 posts
- 13. Nick Shirley 293 B posts
- 14. #SundayMotivation 2.041 posts
- 15. #query 3.067 posts
- 16. Sunderland 29,9 B posts
- 17. Muhammad Qasim 29,1 B posts
- 18. Phrases for Telephone Calls N/A
- 19. Sunday Funday 2.661 posts
- 20. #icecream 3.491 posts
You might like
-
Pete 💙NHS💙 #FBPE
@QuakerPete -
𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏
@CParkMD -
Gary Marsden #FBPE #FBPA #FBPPR 🇪🇺 🇬🇧 🇺🇦
@GaryMar76294673 -
#GetBrexitUndone 🇪🇺
@GetBrexitUndone -
MrPop 💙 vive la république
@StevePoppleton -
Tanhouse1 🇪🇺🏴
@Tanhouse1 -
Sandra
@ynysmon1220 -
Veronica Jackson
@Veronic85988060 -
Smith Jones
@smith_jonesNY -
Aaron Logan, MD, PhD, MPhil
@hemedoc -
to the streets! shut it down!
@streets -
Anne Sheldon
@AnneSheldon_ -
JAAPA
@JAAPAonline -
OncologyEducation
@OncEd -
Spotty Dog
@Spottydog_
Something went wrong.
Something went wrong.